Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-18-007139

SVP & Chief Operating Officer acquired 120,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Nicholson John · SVP & Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-01-31 Exercise or conversion : show line 1 in the form +120,000 $11.34 $1,360,800 392,536 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-01-31 Exercise or conversion : show line 2 in the form Stock Option −120,000 0 D
Loading xslF345X03/doc4.xml…